Investing Profile

Lou Tartaglia

InvestorVCFounder
Partner at Third Rock Ventures
curevc.comBoston, Massachusetts
Photo of Lou Tartaglia, Partner at Third Rock Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
University of California, Berkeley Network
501 CONNECTIONS
Genentech Network
47 CONNECTIONS
cb
$100K - $5.0M
$1.5M
1
$770M
CompanyStageDateRound SizeTotal Raised
Ablexis
Series AJun 2010$12M
$12M
Co-investors: Cary Pfeffer (Third Rock Ventures), Barbara Dalton (Pfizer Venture Investments)
Postdoc GenentechPresent
VP Metabolic Diseases Takeda OncologyPresent
General Manager Ocimum BiosolutionsPresent
Head of 4:59 HotmailPresent
Partner Third Rock VenturesPresent
CEO Solstice Biologics LLCPresent
Venture Partner HotmailPresent
Managing Partner and Co-Founder HotmailPresent
University at Albany Bachelor of Science (B.S.) Chemistry
University at Albany, SUNY Bachelor of Science (B.S.) Chemistry
University of California, Berkeley Doctor of Philosophy (Ph.D.) Biochemistry